logo
Plus   Neg
Share
Email

Sandoz To Appeal U.S. Court Ruling In Biosimilar Erelzi U.S. Patent Case

Sandoz, a Novartis division (NVS), said that the United States District Court of New Jersey ruled against Sandoz in patent litigation regarding the Sandoz biosimilar, Erelzi or etanercept-szzs for reference medicine Enbrel or etanercept. The company will appeal the ruling to the U.S. Court of Appeals for the Federal Circuit, and the parties have agreed to an expedited appeal.

Sandoz said it disagreed with the Court's ruling, which prevents the company from launching an additional treatment option for patients with autoimmune and inflammatory diseases. It continues to consider the patents in this case to be invalid.

According to Sandoz, Amgen asserted two patents that it obtained from Roche, in what Sandoz believes is an attempt to extend its US compound patent protection for etanercept to 2029.oz said, "We will appeal this decision, and look forward to presenting our case to the Federal Circuit and bringing Erelzi to US patients as soon as possible."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Electric Co. filed a lawsuit against Siemens Energy AG, accusing the German power distribution company of stealing trade secrets for gas turbines. Siemens Energy allegedly used the information to get at least nine contracts to supply gas turbines to public utilities, and also covered up improper business gains. Following a court ruling, the U.S. Food and Drug Administration postponed the effective date for tobacco manufacturing companies to display new health warnings on cigarette packets and in advertisements, by additional 90 days. The warnings with color images is to promote greater public understanding of the negative health consequences of smoking. JPMorgan Chase & Co (JPM) reported strong results in the fourth quarter of 2020, with net profit up 42% largely driven by credit reserve releases of $2.9 billion. The Group said it ended the year with a CET1 ratio of 13.1% and capital above $200 billion, providing with meaningful capacity to further...
Follow RTT